In previous studies, we successfully constructed a dual-modality molecular probe that targets pancreatic cancer by utilizing chitosan-encapsulated magnetic nanoparticles as a carrier and targeting the survivin gene. Here, BIRC5 is linked to familial pancreatic carcinoma.